Platelet-derived growth factor receptor β inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: Imatinib and TRAIL dual therapy

Yongxin Wang, Deendayal Mandal, Suizhau Wang, Eugenie S. Kleinerman, Raphael E. Pollock, Dina Lev, Andrea Hayes-Jordan

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Platelet-derived growth factor receptor β inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: Imatinib and TRAIL dual therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences